ABSTRACT
Importance The oral microbiome is increasingly recognized to play key roles in human health and disease; yet, population-representative characterizations are lacking.
Objective Characterize the composition, diversity, and correlates of the oral microbiome among US adults.
Design Cross-sectional population-representative survey.
Setting The National Health and Nutrition Examination Survey (NHANES, 2009-2012), a stratified multistage probability sample of the US population.
Participants NHANES participants aged 18-69 years (n=8,237, representing 202,314,000 individuals).
Exposures Demographic, socioeconomic, behavioral, anthropometric, metabolic, and clinical characteristics.
Main outcomes Oral microbiome, characterized through 16S rRNA sequencing. Microbiome metrics were alpha diversity (number of observed Amplicon Sequence Variants [ASV], Faith’s Phylogenetic diversity, Shannon-Weiner Index, and Simpson Index); beta diversity (unweighted UniFrac, weighted UniFrac, and Bray-Curtis dissimilarity); and prevalence and relative abundance at taxonomic levels (phylum through genus). Analyses accounted for the NHANES complex sample design.
Results Among US adults aged 18-69 years, the oral microbiome encompassed 37 bacterial phyla, 99 classes, 212 orders, 446 families, and 1,219 genera. Five phyla— Firmicutes, Actinobacteria, Bacteroidetes, Proteobacteria, and Fusobacteria and six genera—Veillonella, Streptococcus, Prevotella7, Rothia, Actinomyces, and Gemella, were present in nearly all US adults (weighted-prevalence >99%). These genera also were the most abundant, accounting for 65.7% of abundance. Observed ASVs showed a quadratic pattern with age (peak at 30 years), was similar by sex, significantly lower among non-Hispanic White individuals, and increased with higher body mass index (BMI) categories, alcohol use, and periodontal disease severity. All covariates together accounted for a modest proportion of oral microbiome variability, as measured by beta diversity (unweighted UniFrac=8.7%, weighted UniFrac=7.2%, and Bray-Curtis=6.3%). By contrast, relative abundance of a few genera explained a high percentage of variability in beta diversity (weighted UniFrac: Aggregatibacter=22.4%, Lactococcus=21.6%, Haemophilus=18.4%). Prevalence and relative abundance of numerous genera were significantly associated (Bonferroni-corrected Wald-p<0.0002) with age, race and ethnicity, smoking, BMI categories, alcohol use, and periodontal disease severity.
Conclusions We provide a contemporary reference standard for the oral microbiome of the US adult population. Our results indicate that a few genera were universally present in US adults and a different set of genera explained a high percentage of oral microbiome diversity across the population.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://wwwn.cdc.gov/Nchs/Nhanes/omp/
Funding Statement
This study was funded in part by the Intramural Program of the US National Cancer Institute, National Institutes of Health, by a grant from the US Food and Drug Administration's Center for Tobacco Products (to CCA), and by an NIH National Cancer Institute Informatics Technology for Cancer Research Award (to JGC, 1U24CA248454-01). The NHANES oral HPV protocol that collected oral rinse samples was supported by a grant from the National Institute for Dental and Craniofacial Research (NIDCR) to MLG.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The National Health and Nutrition Examination Survey (NHANES) protocol was approved by the National Center for Health Statistics (NCHS) Ethics Review Board (ERB) and all participants provided written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Updated to include supplemental figures.
Data Availability
Unlinked public-use National Health and Nutrition Examination Survey (NHANES) data files are available on the NHANES website (https://www.cdc.gov/nchs/nhanes). The linked mortality (National Death Index) files are available in a public-use version, available online (https://www.cdc.gov/nchs/data-linkage/mortality.htm), and a restricted-use file available for analysis at the National Center for Health Statistics Research Data Center (https://www.cdc.gov/rdc/index.htm). The restricted-use mortality file was used for this analysis.
